These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10154110)

  • 1. Technology, medicine & health, Part 9. Multi-drug resistance and other "wildcard" diseases.
    Davidson SN
    Healthc Forum J; 1996; 39(1):42-7. PubMed ID: 10154110
    [No Abstract]   [Full Text] [Related]  

  • 2. World tuberculosis control: how far have we to go?
    Enarson DA
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis].
    Wu X; Zhuang Y; Zhang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):332-5. PubMed ID: 10374440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prokaryotic gene therapy to combat multidrug resistant bacterial infection.
    Norris JS; Westwater C; Schofield D
    Gene Ther; 2000 May; 7(9):723-5. PubMed ID: 10822297
    [No Abstract]   [Full Text] [Related]  

  • 7. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 10. [The microbial threat 1. Extension of the resistance problem and its medical consequences].
    Skinhøj P
    Ugeskr Laeger; 1998 Oct; 160(44):6331-3. PubMed ID: 9810233
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress of medicine threatened by drug resistance].
    Sante; 2000; 10(5):363-4. PubMed ID: 11221700
    [No Abstract]   [Full Text] [Related]  

  • 12. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present trends of drug-resistant tuberculosis and how to manage it by mycobacterial laboratories].
    Suzuki K; Tomita M; Kinoshita Y; Yoshida A; Yoshida S; Tsuyuguchi K; Irie A; Yamamoto A; Sakatani M
    Rinsho Byori; 2002 Sep; 50(9):847-52. PubMed ID: 12386961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrating the walls of drug-resistant bacteria: a statutory prescription to combat antibiotic misuse.
    Markow SB
    Georgetown Law J; 1998 Nov; 87(2):531-62. PubMed ID: 10346703
    [No Abstract]   [Full Text] [Related]  

  • 15. Global antibiotic resistance and its impact on the dental community.
    Pallasch TJ
    J Calif Dent Assoc; 2000 Mar; 28(3):215-33. PubMed ID: 11326536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs.
    Laing RO; McGoldrick KM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S194-207. PubMed ID: 11144553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of drug resistance on the global tuberculosis epidemic.
    Schluger NW
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
    [No Abstract]   [Full Text] [Related]  

  • 18. Protecting the public's health against tuberculosis. Moving forward.
    Cetron MS; Castro KG
    J Med Assoc Ga; 2007; 96(2):30. PubMed ID: 18019445
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Health Organization press release. Drug resistant tuberculosis levels ten times higher in Eastern Europe and Central Asia.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1139-40. PubMed ID: 15457608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.